Bladder Cancer Epidemiology report provides an overview of the risk factors and global bladder cancer trends in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of bladder cancer segmented by sex, age (beginning at 15 years and ending at =75 years), and cancer stage at diagnosis (stage 0, stage I, stage II, stage III, and stage IV), in addition to five-year diagnosed prevalent cases in these seven markets.
Complete report on Bladder Cancer Epidemiology Forecast to 2025 spread across 40 pages is available at http://www.reportsnreports.com/reports/807780-epicast-report-bladder-cancer-epidemiology-forecast-to-2025.html
Bladder Cancer Epidemiology forecast is supported by at least 10 years of historical data obtained from country-specific studies published by the World Health Organization’s (WHO),International Agency for Research on Cancer (IARC), the National Cancer Institute’s (NCI) Surveillance, Epidemiology, and End Results (SEER) program, the European Cancer Registry’s fifth database registry (EUROCARE-5), the Center for Cancer Control and Information Services, National Cancer Center (CCCIS, NCC) in Japan, as well as country-specific cancer registries.
Bladder Cancer Epidemiologists forecast that by 2025 the 7MM are expected to have 289,623 diagnosed incident cases of bladder cancer, representing a 23.5% increase from the number of incident cases in 2015 (234,581 incident cases). In 2015, the 7MM had 873,493 five-year diagnosed prevalent cases of bladder cancer and epidemiologists forecast that by 2025, this number will grow to 1,094,707 five-year diagnosed prevalent cases at an Annual Growth Rate (AGR) of 2.53%.
Purchase a Copy of Report at: http://www.reportsnreports.com/purchase.aspx?name=807780 .
The Bladder Cancer Epidemiology Report provides bladder cancer epidemiology report is written and developed by Masters- and PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.Develop business strategies by understanding the trends shaping and driving the global bladder cancer market. Quantify patient populations in the global bladder cancer market to improve product design, pricing, and launch plans. Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for bladder cancer therapeutics in each of the markets covered. Identify the percentage of bladder cancer diagnosed incident cases by stage.
Request Sample Report at http://www.reportsnreports.com/contacts/requestsample.aspx?name=807780
List of tables
Table 1: Bladder Cancer Risk Factors
Table 2: 5EU, Relative Survival of Bladder Cancer (%), Men and Women
Table 3: 7MM, Sources of Bladder Cancer Incidence Data
Table 4: 7MM, Sources of Bladder Cancer Stage at Diagnosis Data
Table 5: 7MM, Sources of Bladder Cancer Relative Survival Data
Table 6: 7MM, Diagnosed Incident Cases of Bladder Cancer, Ages? 15 Years, Both Sexes, N, Select Years 2015-2025
Table 7: 7MM, Age-Specific Diagnosed Incident Cases of Bladder Cancer, Ages? 15 Years, Both Sexes, N (Row %), 2015
Table 8: 7MM, Sex-Specific Diagnosed Incident Cases of Bladder Cancer, Ages? 15 Years, N (Row %), 2015
Table 9: 7MM, Incident Cases of Bladder Cancer by Stage at Diagnosis, Ages? 15 Years, Men and Women, N (Row %), 2015
Table 10: 7MM, Five-Year Diagnosed Prevalent Cases of Bladder Cancer, Ages? 15 Years, Both Sexes, N, Select Years 2015-2025
ReportsnReports.com is your single source for all research needs. Our database includes 500,000+ research reports from over 95 leading global publishers & in-depth research studies of over 5000 micro s. With comprehensive information about the publishers and the industries for which they publish research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
Tel: + 1 888 391 5441